Wells Fargo’s GenVec, Inc. GNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-130
Closed -$1K 6799
2017
Q1
$1K Hold
130
﹤0.01% 6276
2016
Q4
$0 Hold
130
﹤0.01% 6765
2016
Q3
$1K Hold
130
﹤0.01% 6160
2016
Q2
$1K Buy
130
+25
+24% +$175 ﹤0.01% 6065
2016
Q1
$1K Hold
105
﹤0.01% 6160
2015
Q4
$2K Buy
105
+5
+5% +$96 ﹤0.01% 6067
2015
Q3
$2K Hold
100
﹤0.01% 6037
2015
Q2
$2K Hold
100
﹤0.01% 6207
2015
Q1
$3K Buy
100
+50
+100% +$1.64K ﹤0.01% 5958
2014
Q4
$1K Hold
50
﹤0.01% 6173
2014
Q3
$1K Hold
50
﹤0.01% 6150
2014
Q2
$1K Hold
50
﹤0.01% 6079
2014
Q1
$1K Hold
50
﹤0.01% 5835
2013
Q4
$1K Sell
50
-13
-21% -$223 ﹤0.01% 5697
2013
Q3
$1K Hold
63
﹤0.01% 5615
2013
Q2
$0 Buy
+63
New +$531 ﹤0.01% 5939

Wells Fargo's GNVC Position: Q2 2017 in Review

Wells Fargo sold out of GenVec, Inc. (GNVC) in Q2 2017, closing a stake of 130 shares — an estimated $1K sold.

Wells Fargo first reported a position in GNVC in Q2 2013 and held it in 16 quarters. The position peaked at $3K in Q1 2015. 0 funds tracked by Wall St. Rank hold GNVC as of Q2 2017.

  • Wells Fargo reported no remaining GenVec, Inc. position as of Q2 2017 after selling out during the quarter.
  • Wells Fargo sold 130 GenVec, Inc. shares in Q2 2017, an estimated $1K.
  • Wells Fargo first reported a position in GenVec, Inc. in Q2 2013 and held it in 16 quarters.
  • Wells Fargo's GenVec, Inc. position peaked at $3K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held GenVec, Inc. as of Q2 2017.

Based on Wells Fargo's 13F filing for Q2 2017, filed 10 Aug 2017.